Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
09/2008
09/03/2008CN100415673C Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete
09/02/2008US7420081 Methods for synthesizing phosphonic compounds and compounds thereof
09/02/2008US7420074 Process for fluoro derivative-substituted aryl pnictogens and their oxides
09/02/2008US7420070 Resolution with acid; salt formation, cyclization
09/02/2008US7420007 Including the telomers: ethylbutylphospinic salts, butylbutylphosphinic salts, ethylhexylphosphinic salts, butylhexylphosphinic salts, or hexylhexylphosphinic salts; flame-retardant polymer molding materials
09/02/2008US7420000 e.g. 2-((Diethoxvphosphoryl)methylamino)-2-(furan-2-yl)acetic acid; antiinflammatory, antiproliferative agent, viricide, parasiticide; autoimmune, cardiovascular, bone resorption diseases; one-step three-component reaction among amine derivative, carbonyl derivative and organoboron compound
09/02/2008US7419973 Phosphonocephem compound
09/02/2008US7419969 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
09/02/2008CA2386813C Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring
09/02/2008CA2314238C Synthesis of combretastatin a-4 prodrugs and trans-isomers thereof
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008WO2008103707A1 Mono-and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile
08/28/2008WO2008103415A2 Methods of preparing phosphoric acids of combretastatin and derivatives thereof
08/28/2008WO2008101881A2 Alkyl h-phosphonates of n,n'-dialkylimidazoliums and of quaternary ammoniums, and uses thereof
08/28/2008WO2008030115A3 Fluorescent cell markers
08/28/2008US20080207942 Using in coordination catalyst containing transition metal for hydrogenation, phase transfer, cyanation,borating, hydrosilylation
08/28/2008US20080207913 Etherification of biological active materials
08/28/2008US20080207887 oligonucleotide probes; dye attached to probe by electrophilic group consisting of pentafluorophenyl esters and N-hydroxysuccinimide esters
08/28/2008US20080207776 Lipid aggregate for delivery of macromolecules into cells
08/28/2008US20080207568 Class of Gamma Delta T Cells Activators and Use Thereof
08/28/2008US20080207564 Derivaitves of 4-Or 5-Aminosalicylic Acid
08/28/2008US20080207554 Oligonucleotides with phosphotriester linkages; ribonuclease L activators; antineoplastic agents, namely against leukemias, viricides, parasiticides for Chagas' Disease; nucleotide chemical synthesis
08/28/2008US20080207490 Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications
08/28/2008US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
08/28/2008US20080206151 Magnetic resonance imaging (MRI) contrast agent; synthesis by reacting acid-functional group with phosphoethanolamine and then with a peptide; amine containing phospholipids with functional groups in the liposome membrane that are useful as sites for binding
08/27/2008EP1961757A1 Phosphoindoles as HIV inhibitors
08/27/2008EP1961734A1 Amine compound and use thereof for medical purposes
08/27/2008EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
08/27/2008EP1960409A2 Tetraphosphorus ligands for catalytic hydroformylation and related reactions
08/27/2008EP1960057A1 Surface active calcium phosphates
08/27/2008EP1644430B1 Method for producing phosphonate-modified silicones
08/27/2008EP1581474B1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
08/27/2008EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
08/27/2008CN101253184A Phosphorus compound, use thereof and flame-retardant polyester fiber
08/27/2008CN101253183A Process for preparing optically active diphosphanes
08/27/2008CN101250200A Method for synthesizing bis-(2,4-di-tert-butyl phenyl) pentaerythritol diphosphite
08/27/2008CN101250199A Method for preparing diisopropyl phosphite
08/27/2008CN101250198A Method for synthesizing phosphoenolpyruvate potassium pyruvate salt
08/27/2008CN100413873C Ion type liquid
08/27/2008CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
08/26/2008US7417164 Fluorescent dyes, including 8-hydroxypyrene-1,3,6-trislfonic acid (HPTS) and its derivatives; useful for analyte detection, determining blood glucose concentration
08/26/2008US7417065 Therapy, prevention of lymphocyte causing disease; antiinflammatory agents; autoimmune disease
08/26/2008US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole
08/26/2008US7417055 Pharmacokinetics; bioavailability
08/26/2008US7417036 adding organic solvent and dissolivng adefovir dipivoxil ultrasonically to form solution, and spray drying; have different melting points, solubility, and density
08/26/2008US7417035 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
08/26/2008US7416898 Derived from the oxidation of novel alkenes prepared by the coupling of substituted aromatic esters or ketones and spiro-fused ketones with or without a pi -electron system or a carbon-carbon double bond in the ring
08/26/2008CA2397961C Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
08/26/2008CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase
08/21/2008WO2008101147A2 Methods and compositions for regulating bone mineral density
08/21/2008WO2008100316A1 Phosphate-containing flame retardants
08/21/2008WO2008099203A2 Reactions of isotopically enriched elements of phosphorus, sulfur, selenium and tellurium
08/21/2008WO2008098375A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
08/21/2008WO2008098304A1 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging
08/21/2008WO2008076269A3 MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS
08/21/2008WO2006020947A3 Phosphonate fluorescent dyes and conjugates
08/21/2008US20080200744 Trimerisation and oligomerisation of olefins using a chromium based catalyst
08/21/2008US20080200729 Using an organophosphine compound in presence of catalyst, base, ligand and iodine cocatalyst
08/21/2008US20080200695 Complex catalyst which contains noval ligand system and transition metal
08/21/2008US20080200683 Process for Preparing (Alpha S, Beta R)-6-Bromo-Alpha-[2-(Dimethylamino) Ethyl]-2-Methoxy-Alpha-1-Naphthalenyl-Beta-Phenyl-3-Quinolineethanol
08/21/2008US20080200679 Addition of a Grignard reagent or organoindium compound to tetraalkyl carbonylbisphosphonate or trialkyl carbonylbisphosphonacetate
08/21/2008US20080200437 Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases
08/21/2008US20080200425 Methods and compositions for regulating bone mineral density
08/21/2008US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases
08/21/2008US20080199731 Use of a Copper (I) Complexes For Organic Luminescent Diodes
08/21/2008US20080199454 Caspase inhibitor prodrugs
08/20/2008EP1958952A1 Ionic compounds
08/20/2008EP1958951A1 Phosphine transition metal complex, method for producing same and antitumor agent containing same
08/20/2008EP1958950A1 Process for the preparation of dialkylphosphinic acid salts
08/20/2008EP1957509A2 Methods and compositions for the treatment of gastrointestinal disorders
08/20/2008EP1735324B1 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
08/20/2008EP1603927B1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates
08/20/2008CN101248142A Red-shifted water-dispersible naphthalocyanine dyes
08/20/2008CN101248082A Stable water soluble composition containing lysophosphatidylethanolamine and lecithin
08/20/2008CN101248069A Androgen receptor modulators and method of treating disease using the same
08/20/2008CN100412162C Dicyclic phosphonate fire retardant synthesis method
08/20/2008CN100412081C Cobait dipenta cation diphosphine ligand preparation and application thereof
08/20/2008CN100412079C Process for production of phosphine-borane complexes
08/20/2008CN100412078C Fluorine substituted phenoxy acetyl oxide alkyl phosphonate ester and salt with weeding active and preparation process thereof
08/20/2008CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
08/19/2008US7414156 Non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation
08/19/2008US7414155 catalyst system which includes a source of Group VIII metal cations; a diphosphine ligand
08/19/2008US7414151 Process for manufacture of 4-amino-hydroxybutylidene-1, 1-bisphosphonic acid and its salts
08/19/2008US7414076 Methods and compositions for treating amyloid-related diseases
08/19/2008US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases
08/19/2008US7414046 Gyrase inhibitors and uses thereof
08/19/2008US7414040 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
08/19/2008CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
08/19/2008CA2151801C 3'-modified oligonucleotide derivatives
08/14/2008WO2008097674A1 Crosslinkers containing phosphorous
08/14/2008WO2008097483A2 Methods for preparing aryl-substituted ketophosphonates
08/14/2008WO2008096002A1 Hcv inhibiting macrocyclic phosphonates and amidophosphates
08/14/2008WO2008095678A1 Process for the preparation of optically active 2-amino-1-phenylethanols
08/14/2008WO2008051584A3 Process for the preparation of highly purified, dialkydithiophosphinic compounds
08/14/2008WO2008033246A3 Zwitterionic group viii transition metal initiators supported by olefin ligands
08/14/2008US20080194886 Catalysts for nucleophilic substitution, synthesis thereof, composition containing them and use thereof
08/14/2008US20080194853 Novel Iridium Complex and Organic Electroluminescence Device Using the Same
08/14/2008US20080194843 for polymerizing a film-forming resin having a pendant phosphate or phosphonate or phosphinate group and a crosslinkable group; the phosphorous coordinates metals via covalently bonded oxygen atoms; metals are from substrate surface or in the form of metal catalysts; fewer steps and improved adhesion
08/14/2008US20080194831 anion is bis(pentafluoroethyl)phosphinic imide [(C2F5)2P(O)]2N- ; solvents for electrochemical reactions; salt formation